Models of care and the role of clinical pharmacists in UK primary care for older people: findings from a scoping review

Poster ID
2304
Authors' names
Alice Burnand1; Abigail Woodward1; Vlad Kolodin1; Jill Manthorpe2,3; Yogini Jani4; Mine Orlu5; Cini Bhanu1; Kritika Samsi2,3; Victoria Vickerstaff6; Jane Wilcock1; Greta Rait1,6; Nathan Davies1
Author's provenances
(1) Research Department of Primary Care and Population Health, Centre for Ageing Population Studies, University College London; (2) NIHR Policy Research Unit in Health & Social Care Workforce, King’s College London; (3) NIHR Applied Research Collaborative

Abstract

Introduction. Pharmacists have traditionally worked in primary care, in the community, and with GPs. However, the role of the clinical pharmacist in primary care is evolving and there are plans to employ more clinical pharmacists in the NHS. With an ageing UK population, there is an increase in the number of people living with multiple long-term conditions, accompanied by polypharmacy, posing numerous challenges to healthcare systems. This review investigates the evidence about the varied roles and services delivered by clinical pharmacists in primary care, capturing the perspectives of health and care professionals, older adults, and their carers.

Method. Our scoping review followed the framework for scoping reviews in accordance with the Joanna Briggs Institute (JBI) methodology. A broad search was conducted in 2023 in CINAHL, Cochrane, Medline, SCOPUS, and Web of Science. We included articles that explored the landscape of clinical pharmacy services for older people in the UK, focusing on roles and services delivered, perceptions, and experiences.

Results. A total of 23 articles was included. These shed light on the multifaceted responsibilities of clinical pharmacists for older people. Stakeholder perspectives, including healthcare professionals and care home staff, emphasise the positive outcomes of clinical pharmacist involvement, from reducing other practitioners’ workloads to improving patient safety. However, communication gaps amongst the primary care team and those living with dementia, concerns about competence, and the need for clear role definitions of clinical pharmacists emerge as challenges.

Conclusions and implications. The review enhances our understanding of the clinical pharmacist service in the UK and identifies gaps in research evidence, emphasising the need for empirical studies on the experiences of older people with cognitive impairment and those from minority ethnic backgrounds. The findings can be used for policymaking, workforce planning, and healthcare provision to improve the services for older people in the UK.

Presentation